Breast cancer genes a real risk for men, too

April 26, 2018

(HealthDay)—Few American men are screened for gene mutations that can greatly increase their risk of breast and other types of cancers, a new study reveals.

BRCA1 and BRCA2 gene mutations put women at high risk for breast and , but these mutations also increase men's risk for certain cancers.

"If a male has a BRCA mutation, their risk of breast cancer increases 100-fold," said senior study author Dr. Christopher Childers. He is a resident physician in the department of surgery at the University of California, Los Angeles School of Medicine.

"But it's not just breast cancer—BRCA mutations put men at higher risk for often aggressive prostate cancers that occur at younger ages," Childers added in a university news release.

"These mutations have also been associated with other cancers, such as pancreatic cancer and melanoma [skin cancer]," he noted. "It is therefore very important that men at risk of a BRCA mutation get genetic testing, as it can potentially help them detect future cancers and help physicians tailor cancer treatment if they do."

For the new study, Childers and his colleagues analyzed data from the 2015 U.S. National Health Interview Survey. The investigators found that nearly 2.5 million people had received cancer genetic testing. Of those people, nearly three times as many women had testing compared to men—73 percent versus 27 percent, respectively.

Further analysis revealed that the rate of testing for BRCA gene mutations in men was one-tenth that of women. There was no gender disparity in other types of cancer gene tests, the findings showed.

The study was published April 26 in the journal JAMA Oncology.

Further research is needed to learn why so few men get tested for BRCA gene and how to increase their rates, said study lead author Kimberly Childers. She is a genetic counselor and regional manager of the Providence Health and Services Southern California's clinical genetics and genomics program.

"Previous studies have shown that men don't necessarily understand the importance of a breast/ovarian —that it is more of a 'feminine' issue—but this couldn't be further from the truth," she said. "We hope this study will spur broad national educational efforts."

Explore further: Busting myths surrounding cancer and genetic testing

More information: The U.S. National Cancer Institute has more on male breast cancer.

Related Stories

Busting myths surrounding cancer and genetic testing

April 13, 2018
(HealthDay)—While only 5 percent to 10 percent of cancers are caused by an inherited gene mutation, genetic testing may benefit people with a strong history of family cancer, an expert in genetics suggests.

Males with BRCA mutations have increased risk of certain cancers

April 17, 2018
(HealthDay)—Males with BRCA mutations have increased incidence of malignant disease, specifically prostate, melanoma, pancreas, and breast cancers, according to a research letter published online April 12 in JAMA Oncology.

Genetic predisposition to breast cancer due to non-brca mutations in ashkenazi Jewish women

July 20, 2017
Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in Ashkenazi Jewish women. A new article published by JAMA Oncology examines the likelihood of carrying another cancer-predisposing mutation ...

Research test identifies BRCA2 gene mutations that lead to breast, ovarian cancers

January 25, 2018
A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. The research behind the test was published today in the American Journal ...

Risk of a second breast cancer can be better quantified in women carrying a BRCA mutation

March 21, 2018
The risk of a second breast cancer in patients with high-risk BRCA gene mutations can be more precisely predicted by testing for several other genetic variants, each of which are known to have a small impact on breast cancer ...

Mystery of breast cancer risk gene solved, 20 years after its discovery

October 4, 2017
More than 20 years after scientists revealed that mutations in the BRCA1 gene predispose women to breast cancer, Yale scientists have pinpointed the molecular mechanism that allows those mutations to wreak their havoc.

Recommended for you

Scientists discover new method of diagnosing cancer with malaria protein

August 17, 2018
In a spectacular new study, researchers from the University of Copenhagen have discovered a method of diagnosing a broad range of cancers at their early stages by utilising a particular malaria protein that sticks to cancer ...

Pregnant? Eating broccoli sprouts may reduce child's chances of breast cancer later in life

August 16, 2018
Researchers at the University of Alabama at Birmingham have found that a plant-based diet is more effective in preventing breast cancer later in life for the child if the mother consumed broccoli while pregnant. The 2018 ...

Three scientists share $500,000 prize for work on cancer therapy

August 15, 2018
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical ...

PARP inhibitor improves progression-free survival in patients with advanced breast cancers

August 15, 2018
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over ...

New clues into how 'trash bag of the cell' traps and seals off waste

August 15, 2018
The mechanics behind how an important process within the cell traps material before recycling it has puzzled scientists for years. But Penn State researchers have gained new insight into how this process seals off waste, ...

RUNX proteins act as regulators in DNA repair, study finds

August 15, 2018
A study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has revealed that RUNX proteins are integral to efficient DNA repair via the Fanconi Anemia (FA) ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.